Skip to content

TAMedecin

Active Private limited companyfounded 2024active for 2 yearsAvenue des Sapins (N.) 29, 7020 MonsKBO/BCE: BE 1015.564.957

Lifetime

1 annual account with figures
peak of €114,882 in 2025
€114,882 
peak of €88,583 in 2025
€88,583 
peak of €93,583 in 2025
€93,583 
€89,538 
Board3 names since 2024
3 directors and 2 others
Documentsfilings and deeds
20-07-202611 days before the deadline
2025micro format
First year with figures

Key points

from the 2025 annual accounts

Turnover

≈ €290,000 estimated

The micro format states no turnover.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,326 companies had the same profile as TAMedecin has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,326 companies, not a prediction for TAMedecin. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 25-10-2024
Director, since 25-10-2024
Director, since 25-10-2024
  • 100 sharesdeed of 29-10-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1015564957
Incorporation Founding capital of €5,000, 100 shares · Founder: · Appointments: (director), (administrateur uniquement affaires non medicales) and (administrateur uniquement affaires non medicales) · published on 29-10-2024 · Gazette deed
First establishment Rue Jacquet 10, Soignies
All 4 events

Official details

Source: KBO
Status
Active since 25-10-2024Normal situation
Activity
“Toute transaction mobilière et immobilière concernant les locaux médicaux” (deed in French)From the articles, 3 activities1 activity on the establishment unit
Establishment unit
2.365.930.6617061 Soignies, since 25-10-2024
Financial year end
31 December
Peppol
Reachable since 30-09-2025
Company details

Annual accounts 2025

€183,121
Filing
Filed on 20-07-2026, 11 days before the end of the filing period
Financials

Insights on TAMedecin

TAMedecin has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €93,583 and a net result of €88,583.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about TAMedecin

What is the company number of TAMedecin?
The company number of TAMedecin is 1015.564.957. The VAT number is the same number with BE in front: BE 1015.564.957.
Where is TAMedecin based?
The registered office is at Avenue des Sapins (N.) 29, 7020 Mons.Company details
What is the legal form of TAMedecin?
TAMedecin is a private limited company (BV).
When was TAMedecin founded?
TAMedecin was founded on 25-10-2024.
Is TAMedecin still active?
Yes, TAMedecin is an active enterprise in the KBO register.
What is the turnover of TAMedecin?
The turnover in financial year 2025 is ≈ €290,000. This figure is estimated from the gross margin of €114,882 and 2,459 comparable companies of the same size. It probably lies between €190,000 and €440,000. It is a rough estimate.Financials
Is TAMedecin profitable?
In financial year 2025, TAMedecin made a profit of €88,583.
Where can I find the annual accounts of TAMedecin?
TAMedecin filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.